GRS has been increasingly active in the MedTech space over the past few years, with the number one driving factor being the new EU medical device and in-vitro diagnostic regulations which will come into full force as early as April or May this year. It's taken many years to reach this moment but it's here now, it's happening and it's very real.
The impact of these new regulations must not be underestimated and GRS is working hard at delivering a full-service solution to medical device and IVD companies. The company says: "Already we have gained considerable experience assessing European and global portfolios against the new EU regulations and devising strategies on how to achieve compliance during the three or five year transition periods (even though the text isn't absolutely set in stone yet).
"Our fabulous team of MedTech subject matter experts are absolutely critical in ensuring the survival and success of our MedTech clients and this award is a reflection on the superb support and knowledge they provide.
"If you'd like to find out more about how GRS can help you, please call us on +44 (0)1223 750638 or email: GRS@globalregulatoryservices.com."
_______________________________________________